Concepedia

Henry J. Haringsma

HJ

14

Publications

2.5K

Citations

13

H-Index

2007

Active since

Affiliations

Clovis Oncology (United States)(Current)

Harvard University

Dana-Farber Cancer Institute

Broad Institute

University of Cologne

Henry J. Haringsma is an author at Clovis Oncology (United States) specializing in medicine, tumor biology, and lung cancer.

Top concepts

Publications per year

2007–2018

14

Publications

14

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Jacob J. Chabon, Andrew D. Simmons, Alexander F. Lovejoy et al. · Nature Communications · 2016 · 650 citations · Full text

, , +15

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 622 citations · Full text

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Khyati N. Shah, Roma Bhatt, Julia Rotow et al. · Nature Medicine · 2018 · 279 citations · Full text

, , +7

Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy

Danan Li, Takeshi Shimamura, Hongbin Ji et al. · Cancer Cell · 2007 · 234 citations · Full text

, , +9

Inactivation of Capicua drives cancer metastasis

Ross A. Okimoto, Frank Breitenbuecher, Victor Olivas et al. · Nature Genetics · 2016 · 158 citations · Full text

, , +3

Rows per page

1–5 of 14